ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 298

$442K Total Retail Price of All Prescriptions

Rank: 45 out of 298

500 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 500 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 500 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,817 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LISINOPRIL 419 346 1 4
SIMVASTATIN 387 347 2 2
LEVOTHYROXINE SODIUM 351 247 3 1
OMEPRAZOLE 253 190 4 3
AMLODIPINE BESYLATE 247 231 5 6
FUROSEMIDE 231 198 6 5
METOPROLOL SUCCINATE 230 211 7 12
PRAVASTATIN SODIUM 224 176 8 31
TRAMADOL HCL 182 150 9 15
LOSARTAN POTASSIUM 178 173 10 18
ALENDRONATE SODIUM 173 160 11 21
METFORMIN HCL 169 156 12 10
POTASSIUM CHLORIDE 163 113 13 11
TAMSULOSIN HCL 151 136 14 24
HYDROCHLOROTHIAZIDE 138 116 15 13
WARFARIN SODIUM 138 117 15 7
METOPROLOL TARTRATE 133 114 17 9
HYDROCODONE-ACETAMINOPHEN 116 99 S3 18 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 100 19 30
ALLOPURINOL 94 94 20 28
DIGOXIN 91 91 21 27
CARVEDILOL 84 84 22 23
CITALOPRAM HBR 79 67 23 17
GENERLAC 70 0 24 143
SYNTHROID 69 62 25 42
TERAZOSIN HCL 67 54 26 72
FENOFIBRATE 60 33 27 62
OXYBUTYNIN CHLORIDE 60 31 27 81
ADVAIR DISKUS 60 54 27 46
EXELON 58 58 30 132
PAROXETINE HCL 57 51 31 48
ZOLPIDEM TARTRATE 57 37 31 25
CLOPIDOGREL 56 56 33 36
METOCLOPRAMIDE HCL 55 19 34 103
TRAZODONE HCL 54 45 35 39
GLIPIZIDE ER 54 54 35 95
FENTANYL 54 48 S2 35 32
SERTRALINE HCL 52 37 38 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.